Preclinical efficacy of a PSMA-targeted actinium-225 conjugate (225Ac-macropa-pelgifatamab) - a targeted alpha therapy for prostate cancer

待确认 20 由小新发布于 2026/7/13 11:16:11

DOI:10.1158/1078-0432.ccr-23-3746
作者：Christoph A. Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, Monika Klotz, Shankari Nair, Stefan Stargard, Roger M. Bjerke, Katrine Wickstr?m Biseth, Yuan Zeng. Feng, B?rd Indrevoll, Véronique Cruciani,
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Purpose: Initially, prostate cancer responds to hormone therapy but eventually resistance develops. Beta emitter-based PSMA (prostate-specific membrane antigen)-targeted radionuclide therapy

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

21小时前

乐平安

21b6ef087e6a11f1b37e34735aa3bc31.pdf

21小时前

Book学术机器人

2026/7/13 11:16:11 未找到该文献，机器人已退出，请等待人工下载

2026/7/13 11:16:11 Book学术AI机器人收到请求，开始寻找文献

2026/7/13 11:16:11 已向机器人发送请求

21小时前

小新发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyFour Undescribed compounds Isolated from the Aerial Parts of Phyllanthus cochinchinensis with Antimicrobial Activity and NO Production Inhibitory Activity in LPS Activated RAW 264.7 Cells